Elimination of cervical cancer is at the forefront of the global health agenda with the launch of the WHO Initiative for the Elimination of Cervical Cancer in 2018.1 Human papillomavirus (HPV) vaccination is expected to be a priority agenda item on health for the 2020 G20 Summit in Riyadh following the 2019 commitment to universal access to vaccination in the G20 Osaka Leaders' Declaration2 and the Okayama Declaration of the G20 Health Ministers.3 This political momentum should be coupled with the latest evidence to pinpoint outstanding areas for action and to implement responsive strategies.